NPYFa, A Chimeric Peptide of Met-Enkephalin, and NPFF Induces Tolerance-Free Analgesia (Q48255291)

10 February 2018

http://europepmc.org/abstract/MED/26802437

title

NPYFa, A Chimeric Peptide of Met-Enkephalin, and NPFF Induces Tolerance-Free Analgesia (English)

1 reference

10 February 2018

http://europepmc.org/abstract/MED/26802437

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26802437%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26802437%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Annu Mudgal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26802437%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Krishan Kumar

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26802437%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

23 January 2016

1 reference

10 February 2018

http://europepmc.org/abstract/MED/26802437

published in

Chemical Biology and Drug Design

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26802437%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26802437%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26802437%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

885-894

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26802437%20AND%20SRC:MED&resulttype=core&format=json

Met-enkephalin-Arg6-Phe7, present in high amounts in brain of rat, cattle and man, is an opioid agonist

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

The action of FMRFamide (Phe-Met-Arg-Phe-NH2) and related peptides on mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Receptor selectivity of Met-enkephalin-Arg6-Phe7, an endogenous opioid peptide, in cerebral cortex of human and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Met5-enkephalin-Arg6-Phe7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Inhibition of spontaneous and opiate-modified nociception by an endogenous neuropeptide with Phe-Met-Arg-Phe-NH2-like immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Existence of antiopiate systems as illustrated by MIF-1/Tyr-MIF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

A review of the role of anti-opioid peptides in morphine tolerance and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

FMRF-NH2-like mammalian octapeptide: possible role in opiate dependence and abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Downregulation of mu-opioid binding sites following chronic administration of neuropeptide FF (NPFF) and morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

G-protein-coupled receptor heteromers: function and ligand pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Opioid-receptor-heteromer-specific trafficking and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Rational design of dualsteric GPCR ligands: quests and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Receptor heteromerization and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Regional distribution of methionine-enkephalin-Arg6-Phe7 in the rat brain: comparative study with the distribution of other opioid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Modulatory roles of the NPFF system in pain mechanisms at the spinal level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Modulatory role of neuropeptide FF system in nociception and opiate analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Opioid-modulating properties of the neuropeptide FF system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Neuropeptide FF and modulation of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Assessing activation of the human neuropeptide FF2 receptor with a non-radioactive GTP binding assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Peptide-membrane interactions and a new principle in quantitative structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Comparative modeling of human kappa opioid receptor and docking analysis with the peptide YFa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Basic concepts in G-protein-coupled receptor homo- and heterodimerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

In vivo opioid receptor heteromerization: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

GPCR heteromers and their allosteric receptor-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Conformational analysis of dynorphin A (1-13) using hydrogen-deuterium exchange and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Opioid-modulating peptides: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Opposite effects of neuropeptide FF on central antinociception induced by endomorphin-1 and endomorphin-2 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

(-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Dynorphin-(1-13), an extraordinarily potent opioid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721

Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12721